DS
ACUR

David Shaw’s Acura Pharmaceuticals ACUR Stock Holding History

David Shaw’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,210
Closed -$12K – 4584
2014
Q2 		$12K Sell
2,210
-101
-4% -$612 ﹤0.01% 4131
2014
Q1 		$17K Buy
+2,311
New +$20.1K ﹤0.01% 4220
2013
Q3 		– Sell
-15,216
Closed -$143K – 4569
2013
Q2 		$143K Buy
+15,216
New +$172K ﹤0.01% 3825

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

David Shaw's ACUR Position: Q3 2014 in Review

David Shaw sold out of Acura Pharmaceuticals (ACUR) in Q3 2014, closing a stake of 2,210 shares — an estimated $12K sold.

David Shaw first reported a position in ACUR in Q2 2013 and held it in 3 quarters. The position peaked at $143K in Q2 2013. 28 funds tracked by Wall St. Rank hold ACUR as of Q3 2014.

  • David Shaw reported no remaining Acura Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • David Shaw sold 2,210 Acura Pharmaceuticals shares in Q3 2014, an estimated $12K.
  • David Shaw first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • David Shaw's Acura Pharmaceuticals position peaked at $143K in Q2 2013.
  • 28 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2014.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.